The COVID-19 pandemic as a catalyst for innovation: a regulatory framework to assess fit-for-purpose innovative approaches in clinical research
Abstract The COVID-19 pandemic has had a devastating impact on individuals and multiple aspects of our society including healthcare and clinical research. The silver lining is that the pandemic also served as a catalyst for wider adoption of innovative approaches in clinical research, notably the us...
Main Authors: | Lada Leyens, Tracy Simkins, Nafsika Kronidou Horst |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-022-06707-w |
Similar Items
-
Enhancing Patient Centricity and Advancing Innovation in Clinical Research with Virtual Randomized Clinical Trials (vRCTs)
by: Raphael A. Yaakov, et al.
Published: (2021-01-01) -
Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials
by: Eliya Farah, et al.
Published: (2023-09-01) -
Attitude and perception toward clinical trials in India among patients and patient bystanders visiting the Indian Ophthalmology Clinical Trial Network: A multi-centric, cross-sectional survey
by: Gopal S Pillai, et al.
Published: (2023-01-01) -
Differences in eConsent among diagnosis groups
by: Deborah Profit, et al.
Published: (2023-10-01) -
Patient and Patient Group Engagement in Cancer Clinical Trials: A Stakeholder Charter
by: Stéphanie Michaud, et al.
Published: (2021-04-01)